WHO prequalifies Novartis' antimalarial Coartem Baby for treatment of newborns and young infants Manufacturing Chemist 11:30 Wed, 29 Apr
Novartis malaria treatment Coartem® Baby receives WHO prequalification BioSpectrum Asia 12:50 Sun, 26 Apr
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants Novartis (Press Release) 06:20 Fri, 24 Apr
